Suppr超能文献

开始或改变治疗——一项探索抗逆转录病毒治疗决策的前瞻性研究。

Starting or changing therapy - a prospective study exploring antiretroviral decision-making.

作者信息

Fehr J S, Nicca D, Sendi P, Wolf E, Wagels T, Kiss A, Bregenzer T, Vernazza P, Jäger H, Spirig R, Battegay M

机构信息

Division of Infectious Diseases, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.

出版信息

Infection. 2005 Aug;33(4):249-56. doi: 10.1007/s15010-005-4141-1.

Abstract

BACKGROUND

When to start or change antiretroviral treatment against HIV infection is of major importance. Patients' readiness is considered a major factor influencing such treatment decisions, in particular because no objective, absolute time point when to start antiretroviral therapy exists. We aimed at evaluating patients' readiness to start or change antiretroviral therapy (ART).

PATIENTS AND METHODS

HIV-infected patients starting or changing ART between July 2002 and February 2003, treating physicians and nurses participated in this prospective, observational multicenter study. We assessed shared decision-making including qualitative aspects, expected treatment decisions and treatment status after 3 months.

RESULTS

75 patients were included. Of 34 patients for whom starting ART was considered, 27 (79%) indicated that they were willing to start treatment. After 3 months, 21 of 27 (78%) actually started therapy, six did not. Patients with depression were less likely to be ready for ART (p < 0.05). Of 41 patients for whom changing ART was considered, 35 (85%) indicated that they were willing to change treatment. Of the latter 35 patients, 33 (94%) finally changed ART within 3 months. Physicians and nurses were too optimistic in predicting the start or change of ART. The main reason to start or change ART was the sole recommendation of the physician (52% in those starting, 61% in those changing ART). Patients mainly judged the decision as shared and were very satisfied (71%) with the process. Qualitative findings revealed the importance of a dialectic decisionmaking, described with two categories: "dealing with oneself and others"' and "understanding and being understood."

CONCLUSION

Patients mainly shared the decision made during consultation. Although physicians have an essential role concerning ART, patients, physicians, and nurses all contribute to the decision. Qualitative findings indicate the importance for health-care providers to include patients' expertise and contributions.

摘要

背景

何时开始或改变针对艾滋病毒感染的抗逆转录病毒治疗至关重要。患者的意愿被视为影响此类治疗决策的主要因素,特别是因为不存在开始抗逆转录病毒治疗的客观、绝对时间点。我们旨在评估患者开始或改变抗逆转录病毒治疗(ART)的意愿。

患者与方法

2002年7月至2003年2月期间开始或改变抗逆转录病毒治疗的艾滋病毒感染患者、治疗医生和护士参与了这项前瞻性观察性多中心研究。我们评估了共同决策,包括定性方面、预期治疗决策和3个月后的治疗状态。

结果

纳入75例患者。在34例被考虑开始抗逆转录病毒治疗的患者中,27例(79%)表示愿意开始治疗。3个月后,27例中的21例(78%)实际开始治疗,6例未开始。抑郁症患者开始抗逆转录病毒治疗的意愿较低(p<0.05)。在41例被考虑改变抗逆转录病毒治疗的患者中,35例(85%)表示愿意改变治疗。在这35例患者中,33例(94%)最终在3个月内改变了抗逆转录病毒治疗。医生和护士在预测抗逆转录病毒治疗的开始或改变方面过于乐观。开始或改变抗逆转录病毒治疗的主要原因是医生的唯一建议(开始治疗的患者中为52%,改变抗逆转录病毒治疗的患者中为61%)。患者主要认为该决策是共同做出的,并对该过程非常满意(71%)。定性研究结果揭示了辩证决策的重要性,分为两类描述:“与自己和他人打交道”以及“理解与被理解”。

结论

患者主要参与了会诊期间做出的决策。尽管医生在抗逆转录病毒治疗方面起着至关重要的作用,但患者、医生和护士都对决策做出了贡献。定性研究结果表明,医疗服务提供者纳入患者的专业知识和贡献非常重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验